COVID-19

CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares

Calgary, Alberta--(Newsfile Corp. - February 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

11 months ago

Rural healthcare leaders prioritize cybersecurity, revenue optimization and AI investments

Optimism grows as rural healthcare organizations adapt to post-pandemic challenges MILWAUKEE, Feb. 4, 2025 /PRNewswire/ -- Wipfli, a top 25…

11 months ago

Catheter Precision, Inc.  Announces The Closing of its Acquisition of PeriKard, LLC

FORT MILL, S.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device…

11 months ago

Hemostemix Expands to the Dominican Republic

Calgary, Alberta--(Newsfile Corp. - February 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

11 months ago

Pharmacy Increases Revenue 52% for Vaccine Delivery Using Workflow Services

Medical billing platform has streamlined patient encounters by automating claim submissions and resolving issues with payors, new case study shows…

11 months ago

Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill

SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…

11 months ago

Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation

Rebranding Signals Strategic Shift Beyond Biopharmaceuticals, Highlights Commitment to Technology, Artificial Intelligence and Shareholder Value WEXFORD, Pa., Jan. 30, 2025…

11 months ago

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Cognizant will provide AI-driven solutions to enhance customer service, employee engagement, and business value TEANECK, N.J., Jan. 30, 2025 /PRNewswire/…

11 months ago

Hemostemix Announces First Sales Orders for ACP-01

Calgary, Alberta--(Newsfile Corp. - January 29, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

11 months ago